Table 1.
Clinical parameters and staging for 32 breast cancer patients, along with bone marrow immunomagnetic selection data
| IM EpCAM- positive cells |
Patients | Hormonal receptor- positivea |
Her2/neu positivea |
Histology | Tumor grade |
Tumor size | 2002 AJCC nodes pN |
2002 AJCC stage |
Patient 'disease' group |
| 103 | PM549 | 1 | 0 | DI | II | NA | 3 | IV | 'Advanced' |
| 179 | PM551 | 1 | 0 | DI | III | T3 | 2 | IIIA | 'Advanced' |
| 214 | PM552 | 0 | 0 | DI | III | T4 | 2 | IIIB | 'Advanced' |
| 42 | PM557 | 1 | 0 | DI | II | T1 | 0 | I | 'Localized' |
| 7 | PM566 | 1 | 0 | DI | I | T1 | 0 | I | 'Localized' |
| 17 | PM567 | 1 | 0 | DI | II | T1 | 1 | IIA | 'Localized' |
| 7 | PM568 | 1 | 0 | DI | II | T2 | 1 | IIA | 'Localized' |
| 180 | PM572 | 1 | 0 | DI | III | T2 | 2 | IIIA | 'Advanced' |
| 101 | PM596 | 1 | 0 | DI | I | T1 | 0 | I | 'Localized' |
| 37 | PM597 | 1 | 1 | LI | II | T1 | 0 | I | 'Localized' |
| 278 | PM598 | 1 | 1 | DI | II | T4 | 2 | IIIB | 'Advanced' |
| 255 | PM601 | 0 | 0 | DI | III | NA | 0 | IV | 'Advanced' |
| 358 | PM602 | 1 | 1 | DI | III | T4 | NA | IIIB | 'Advanced' |
| 142 | PM603 | 1 | 1 | DI | III | T4 | 2 | IIIB | 'Advanced' |
| 146 | PM608 | 1 | 0 | DI | I | T1 | 0 | I | 'Localized' |
| 229 | PM609 | 0 | 0 | DI | III | T2 | 0 | IIA | 'Localized' |
| 162 | PM612 | 1 | 0 | DI | II | T3 | 2 | IIIA | 'Advanced' |
| 143 | PM613 | 1 | 0 | DI | I | T1 | 0 | I | 'Localized' |
| 115 | PM615 | 1 | 0 | DI | II | T2 | 0 | IIA | 'Localized' |
| 215 | PM618 | 1 | 0 | LI | III | NA | 3 | IV | 'Advanced' |
| 140 | PM620 | 1 | 0 | DI | III | T3 | 3 | IIIC | 'Advanced' |
| 67 | PM631 | 1 | 0 | LI | II | T3 | 3 | IIIC | 'Advanced' |
| 172 | PM632 | 0 | 0 | DI | III | NA | 3 | IV | 'Advanced' |
| 345 | PM634 | 1 | 1 | DI | II | T3 | 2 | IIIA | 'Advanced' |
| 87 | PM635 | 1 | 0 | LI | NA | T4 | 2 | IIIB | 'Advanced' |
| 79 | PM642 | 1 | 0 | DI | I | T4 | 2 | IIIB | 'Advanced' |
| 162 | PM643 | 0 | 0 | DI | III | T4 | 0 | IIIB | 'Advanced' |
| 105 | PM644 | 0 | 1 | DI | III | T3 | 3 | IIIC | 'Advanced' |
| 223 | PM649 | 1 | 0 | DI | III | T2 | 2 | IIIA | 'Advanced' |
| 88 | PM655 | 1 | 0 | DI | III | T2 | 2 | IIIA | 'Advanced' |
| 216 | PM656 | 1 | 0 | LI | II | T4 | 1 | IIIB | 'Advanced' |
| 458 | PM658 | 1 | 0 | LI | I | T2 | 3 | IIIC | 'Advanced' |
AJCC, American Joint Committee on Cancer; DI, ductal invasive; EpCAM, Epithelial Cell Adhesion Molecular; IM, immunomagnetic; LI, lobular invasive; NA, not available; pN, pathologic lymph node status a1, positive; 0, negative.